LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microrheological Method Determines Blood Type

By LabMedica International staff writers
Posted on 13 Aug 2013
Image: Scheme of microfluidic apparatus for blood typing (Graphics courtesy of the Polish Institute of Physical Chemistry).
Image: Scheme of microfluidic apparatus for blood typing (Graphics courtesy of the Polish Institute of Physical Chemistry).
The development of microfluidic blood-typing assays can reduce the time of analysis, and enable simultaneous determination of the most clinically important antigens.

A method for typing and subtyping blood has been developed in a simple microfluidic system that monitors the speed of flow of microdroplets and determining agglutination in small samples of liquid.

Scientists at the Institute of Physical Chemistry of the Polish Academy of Sciences (Warsaw, Poland) have demonstrated a microfluidic method for reproducible and objective determination of agglutination in small, nanoliter quantities of liquid. They demonstrated the reliability of the method on the model example of determination of blood type, yet the method should also be possible to use with the wide range of agglutination assays used in in vitro diagnostics.

The investigators tested agglutination in droplets with A, B and O blood groups, and then a second series of agglutination test in droplets with different Rh factors. Each series was performed for both standardized red blood cells and human blood samples. The red blood cells were not removed from the whole blood before these tests. In each series a droplet with antibodies was linked in the merging chamber with a droplet containing red blood cells. The merging chamber was equipped with two electrodes connected to a source of alternating current (AC) electrostatic potential. An oscillating electric field speeds up the coalescence of droplets arriving from the individual T-junctions. A created droplet was sent to the section of measurement for the time of flow.

The method had a very high sensitivity and reliability. The reliability approached 100% with an estimated chance of mistyping on the order of one per million samples. The method of detection of agglutination could potentially be used for automating various agglutination assays. The authors noted that the method offers the potential benefits of a reduction of the volume of blood sample to single microliters for the whole test, the lack of requirement for preprocessing such as centrifugation, and eliminating any subjectivity from the procedure.

Importantly, the method could be compliant both with a point-of-care format for the simplest blood-typing protocols and with multiplexed assays for complex analyses, such as cross-match testing or other multiple antigen determinations in a bench-top format. The study was published on June 18, 2013, in the journal Lab on a Chip.

Related Links:
Polish Institute of Physical Chemistry

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Gold Member
Hematology Analyzer
Medonic M32B

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more